Hematology Today—March 23, 2026
This week’s Hematology update highlights hemophilia gene therapy supply…
Lucid Diligence Brief: Cognito Therapeutics $105 million Series C
Lucid Diligence Brief: Cognito Therapeutics $105 million Series C Professional…
Lucid Diligence Brief: Poplar Therapeutics $95 million Series A
Lucid Diligence Brief: Poplar Therapeutics $95 million Series A extension…
Rare Diseases Today—February 26, 2026
This week's Rare Disease update summarizes regulatory actions (orphan…
Endocrinology Today—February 24, 2026
This week's Endocrinology update covers guideline and labeling changes,…
Lucid Diligence Brief: Gilead to acquire Arcellx (anito-cel)
Lucid Diligence Brief: Gilead to acquire Arcellx (anito-cel) Professional…
Lucid Diligence Brief: Candel Therapeutics $100m funding for CAN-2409 in localized prostate cancer
Lucid Diligence Brief: Candel Therapeutics $100m funding for CAN-2409 in…
Oncology Video Recap—February 16, 2026
This biweekly Oncology video recap is covering key developments across the…
Lucid Diligence Brief: Disc Medicine bitopertin FDA CRL
Lucid Diligence Brief: Disc Medicine bitopertin FDA CRL Professional audiences…
Endocrinology Video Recap—February 10, 2026
Biweekly Endocrinology video recap covering regulatory actions, clinical…
Cell and Gene Therapy Video Recap—February 5, 2026
This biweekly Cell and Gene Therapy video recap summarizes key developments,…
Lucid Diligence Brief: Galderma resubmits RelabotulinumtoxinA to the FDA
Lucid Diligence Brief: Galderma resubmits RelabotulinumtoxinA to the FDA…